Owing to the controversial role of CCND2 in different type of tumors, we aimed to assess the expression of CCND2 and the status of promoter methylation in RCC cell lines, tumors and adjacent non-malignant tissues. Here, CCND2 is linked to renal cell adenocarcinoma.